Pharos’ AI-Designed Leukemia Drug Earns Orphan Designation in Europe Pharos iBio, a South Korea-based biotech specializing in AI-driven drug discovery, announced that its lead investigational asset PHI-101,… Won Jonghyuck 2025-06-24